Cadrenal Therapeutics, Inc. (CVKD)
Total Valuation
CVKD has a market cap or net worth of $9.77 million. The enterprise value is $1.38 million.
Market Cap | 9.77M |
Enterprise Value | 1.38M |
Important Dates
The last earnings date was Monday, March 11, 2024, before market open.
Earnings Date | Mar 11, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CVKD has 13.02 million shares outstanding. The number of shares has increased by 70.99% in one year.
Shares Outstanding | 13.02M |
Shares Change (YoY) | +70.99% |
Shares Change (QoQ) | +4.22% |
Owned by Insiders (%) | 47.04% |
Owned by Institutions (%) | 3.45% |
Float | 7.97M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.27 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.27, with a Debt / Equity ratio of 0.00.
Current Ratio | 10.27 |
Quick Ratio | n/a |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -487.69 |
Financial Efficiency
Return on equity (ROE) is -141.20% and return on invested capital (ROIC) is -98.95%.
Return on Equity (ROE) | -141.20% |
Return on Assets (ROA) | -129.20% |
Return on Capital (ROIC) | -98.95% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.09M |
Employee Count | 4 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.79% in the last 52 weeks.
Beta (1Y) | n/a |
52-Week Price Change | -50.79% |
50-Day Moving Average | 0.89 |
200-Day Moving Average | 0.83 |
Relative Strength Index (RSI) | 44.78 |
Average Volume (30 Days) | 355,383 |
Short Selling Information
The latest short interest is 21,914, so 0.17% of the outstanding shares have been sold short.
Short Interest | 21,914 |
Short Previous Month | 7,168 |
Short % of Shares Out | 0.17% |
Short % of Float | 0.27% |
Short Ratio (days to cover) | 0.01 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -7.63M |
Pretax Income | -8.36M |
Net Income | -8.36M |
EBITDA | -8.34M |
EBIT | -8.34M |
Earnings Per Share (EPS) | -$0.62 |
Balance Sheet
The company has $8.40 million in cash and $21,350 in debt, giving a net cash position of $8.38 million or $0.64 per share.
Cash & Cash Equivalents | 8.40M |
Total Debt | 21,350 |
Net Cash | 8.38M |
Net Cash Per Share | $0.64 |
Equity / Book Value | 7.69M |
Book Value Per Share | 0.59 |
Working Capital | 7.67M |
Cash Flow
In the last 12 months, operating cash flow was -$3.53 million and capital expenditures -$3,254, giving a free cash flow of -$3.53 million.
Operating Cash Flow | -3.53M |
Capital Expenditures | -3,254 |
Free Cash Flow | -3.53M |
FCF Per Share | -$0.26 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CVKD does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -70.99% |
Shareholder Yield | -70.99% |
Earnings Yield | -85.58% |
FCF Yield | -36.19% |
Analyst Forecast
The average price target for CVKD is $3.50, which is 446.88% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $3.50 |
Price Target Difference | 446.88% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | -1.98% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |